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NUTRITIONAL STATUS AND GI SYMPTOMS IN PEDIATRIC
PATIENTS WITH CYSTIC FIBROSIS
David Griego, Ashley Deschamp, MD, MS, Barb Bice, RD, MS, Dee Acquazzino, BS
Children’s Hospital & Medical Center, Omaha, NE; University of Nebraska Medical
Center, Omaha, NE; Creighton University, Omaha, NE
Background

Results

• Cystic Fibrosis (CF) is a genetic disorder that affects many organ systems including the lungs and the
gastrointestinal tract. It is caused by a mutation in the CFTR gene which creates a defective protein that poorly
regulates the flow of chloride ions across the cell membrane. This defect causes viscous mucus to accumulate,
decreasing lung function and providing an environment for bacteria to colonize. In the GI tract, this defect can lead
to serious complications including poor digestion, poor nutrient absorption, increased inflammation, and
abnormalities in the gut microbiota1. Without treatment, these problems can lead to malnourishment and adverse
GI symptoms.
• Approximately 60 to 90% of people with CF suffer from exocrine pancreatic insufficiency (EPI) due to mucous
blockage which, in turn, inhibits the release of enzymes needed for digestion1. Pancreatic Enzyme Replacement
Therapy (PERT) provides patients with the necessary enzymes (amylase, lipase, and protease) that help improve
digestion and absorption. Despite PERT, CF patients often have difficulty absorbing enough calories, fat, protein,
and fat-soluble vitamins to maintain healthy weight. To account for deficiencies in these nutrients, higher dietary
intakes (DRIs) are recommended for people with CF. Maintaining healthy nutritional status can improve the overall
health of the lungs and digestive system. Adequate nutritional status leads to less severe symptoms and increased
ability to fight off infection2.
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• Our CF participants were deficient in non-fermentable fiber (52%), vitamin A (48%), vitamin E (96%), and vitamin K
(100%). The non-CF siblings were deficient in nonfermentable fiber (60%), vitamin E (40%), and vitamin K (30%).
• Both CF participants and non-CF participants consumed excessive amounts of several nutrients. CF participants
consumed excessive calcium (87%), zinc (87%), sodium (87%), iron (91%), and magnesium (83%). Non-CF
participants consumed excessive calcium (90%), zinc (70%), sodium (100%), magnesium (70%), and vitamin A
(50%). Significant differences were observed between CF and non-CF nutrient intakes of zinc (p=0.05), iron
(p=0.04), vitamin A (p=0.03), vitamin E (p=0.003), vitamin C (p=0.05), and vitamin B-12 (p=0.03).
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Figure 1: Overall macronutrient intake for CF and non-CF participants. No significant difference was
observed between macronutrient intake for CF and non-CF groups. No significant difference in mean total
calorie intake was observed between CF and non-CF groups (mean 2749 kcal vs 2733 kcal, respectively).
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• Deficient intake of fat-soluble vitamins was most common in CF participants, likely because their RDAs were four to
nine times higher than the RDAs of healthy individuals. Both CF and non-CF participants consumed excess amounts
of the same nutrients: calcium, zinc, sodium, and magnesium. Excessive values for calcium and zinc came largely
from consumption of milk, cheese, and pizza. Excessive values for magnesium came from milk, peanut butter and jelly
sandwiches, and energy bars. Lastly, excessive iron levels can be traced back to frequent consumption of cereal and
pancakes.
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• The data from the food frequency questionnaire was analyzed to determine the approximate nutrient composition of
each food or drink that was reported. These nutrients were then compiled and summarized for each participant. A
food intake summary was constructed to contain average daily amounts for 30 different nutrients. These included:
calories, carbohydrates, proteins, fats, fibers, vitamins, and minerals.
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• The food intake summary was categorized by gender and age group (Ages 3-8; 4-9; 9-13; 14-18). These averages
were then directly compared to a chart of daily reference intakes (DRIs) unique to guidelines for children with CF3 and
healthy children without CF4. Based on DRIs for each gender and age group, average nutrient intakes were deemed
sufficient, deficient, or excessive.
• Nutrient intake averages for CF participants and non-CF siblings were compared using t-tests with unequal variances.
• Frequency of GI symptoms was collected for CF participants and non-CF siblings. These symptoms included
presence of: diarrhea, constipation, bloated, oily stool (steatorrhoea), excessive flatus, abdominal pain, and
decreased appetite. Relative frequency of GI symptoms was compared for CF participants and non-CF siblings and
for CF participants alone based on genotype (homozygous ∆F508 and heterozygous ∆F508 ).
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Figure 2: Summary of GI symptoms for CF and non-CF participants. CF participants experienced
GI symptoms more frequently than non-CF participants. Bloated: 65% of CF participants reported
feeling bloated while only 20% of non-CF participants did; Oily Stool: 52% of CF participants reported
having oily stool while zero non-CF participants did. Excessive Gas: 69% of CF participants reported
excessive gas while only 10% of non-CF participants did ; Abdominal Pain: 61% of CF participants
reported abdominal pain while only 20% of non-CF participants did.
GI Symptoms by CF Genotype

• An obvious difference in GI symptom frequency was observed between CF and non-CF participants. The presence of
cystic fibrosis explains the prevalence of these GI symptoms. Studies have shown that patients with the homozygous
f508del mutation can have higher degrees of exocrine pancreatic insufficiency (EPI), potentially contributing to more
severe GI symptoms5. Fecal elastase levels below 184 mcg/g are diagnostic of pancreatic insufficiency. Our
homozygotes were more depleted in fecal elastase compared to the heterozygotes (mean 83.1 mcg/g vs 133.4 mcg/g,
respectively). These differences in fecal elastase were not statistically significant (p = 0.25). Sweat chloride levels
varied significantly by genotype (p = 0.02). Sweat chloride levels of 60 mmol/L or higher are diagnostic of cystic
fibrosis. In our sample, homozygotes had higher sweat chloride levels compared to heterozygotes (mean 88.7 mmol/L
vs 68.3 mmol/L, respectively). Previous studies have shown that higher sweat chloride levels are associated with
failure to thrive (FTT) and more frequent steatorrhoea6. Our observations of GI symptoms by genotype support this.
• The main limitation of our study came from the ambiguity of RDA values found for healthy individuals and individuals
with cystic fibrosis. Inconsistencies in published RDA values from various sources caused us to choose wider ranges
to assess “adequate” intake.
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• All participants were eating well and meeting their macronutrient goals.
• Some dietary deficiencies existed in CF participants, including non-fermentable fiber, and vitamins A, E, and K. Exploring
their clinical effects will be a future area of focus.
• GI symptoms were common in participants with CF, highlighting the need for interventions in this area.
• Not unexpectedly, GI symptoms in homozygous f508del patients were more frequent than heterozygous f508del patients.
• These findings will be used in larger analyses to assess links between dietary intake and composition of the gut
microbiome. Future directions may include using dietary modification to benefit the gut microbiome and GI symptoms in
kids with CF.
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To evaluate the nutritional intake and frequency of GI symptoms in CF participants compared to their non-CF siblings.

• This study measured nutritional intake and symptomatology of CF participants and their siblings. No difference was
observed in macronutrient intake between CF participants and their siblings. This could likely be attributed to similar
meals being eaten among all members of the household. However, differences in micronutrient intake were present.
According to the CFF, it is important that CF patients consume more calories, fat, fiber, zinc, sodium, and fat-soluble
vitamins than an individual without the disease3. This was achieved in the participants studied.
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• Participants with CF and their siblings without CF were recruited for this study. Each participant completed a food
frequency questionnaire and a GI symptom questionnaire, prompting them to answer questions about the frequency
and severity of their symptoms.
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Figure 3: Summary of GI symptoms between homozygous ∆F508 and heterozygous ∆F508 CF participants. On
average, homozygous ∆F508 participants experienced GI symptoms 20% more frequently than heterozygous ∆F508
participants. Homozygous ∆F508 reported: Constipation & Ate less: 35% more; Abdominal pain: 25% more; Bloated,
Oily Stool, Reflux: 15% more; Excessive gas: 10% more.
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